RxDoctor Payments Data

Christina Rice

Nurse Practitioner · Blacksburg, VANPI 1083357776

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.6% of the total across 251 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 27.4% of the total. 2025 is the largest year on record at $2,330, 7.0 times the $334 reported in 2022. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,887in general payments, 2019–2025

Across 251 payments — averaging $23.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Amgen$425
  • Regeneron Healthcare Solutions, Inc.$422
  • Arcutis Biotherapeutics, Inc.$394
  • Lilly USA, LLC$366
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$5,45293%
  • Education$4357%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,887 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$3,195
Medicare patients
23
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab37$366,659
Skyrizi PenRisankizumab-Rzaa14$299,823
Dupixent PenDupilumab38$150,672
Clobetasol Propionate187$8,055
Halobetasol Propionate36$3,308
Fluorouracil39$3,303
Tretinoin36$2,793
Ketoconazole174$2,499
Doxycycline Hyclate74$1,151
Ammonium Lactate26$1,148
Triamcinolone Acetonide78$1,110
Metronidazole21$1,017
Clindamycin Phosphate25$1,016
Econazole Nitrate20$860
Ciclopirox18$607

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Blacksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →